USD 30.4 billion
Report ID:
SQMIG35J2071 |
Region:
Global |
Published Date: February, 2025
Pages:
219
|Tables:
63
|Figures:
77
Cell Expansion Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 33.53 billion in 2024 to USD 73.46 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).
The advancement in solutions used in cell expansion is one of the major drivers of the market. Processing systems reduce manpower and costs during the development of cell therapy (CTP), gene therapy, and other biological therapies, and reliable results.
Key players involved in the development of CTP are expanding their product range to meet the significantly increased global demand for these compounds. The paradigm shift to single-use systems (SUS) provides significant productivity gains in CTP operations. SUS eliminates concerns about cross-contamination and culture contamination caused by improper sterilization. SUS also allows CTP to be produced with higher cell density and results in lower costs in the long term. Thus, an increase in SUS adoption boosts the production of CTPs, boosting cell expansion market growth.
Cell therapy continues to be popular in the life sciences field. Significant increase in investments from private & government organizations and initiatives to promote cell therapy development are acting as market leaders. The International Society for Stem Cell Research is involved in developing funding opportunities for stem cells in biomedical research.
Substitution of serum and other incompatible reagents is essential to control the quality of the product in CTP manufacturing. Several research studies have validated that applying serum-free media controls product quality. Cellular therapies are constantly gaining popularity in the life sciences industry. A significant rise in funding from private & government organizations and initiatives undertaken by them to encourage the development of cellular therapies act as drivers for the market. The International Society for Stem Cell Research is involved in identifying stem cell-related funding opportunities across biomedical research applications.
US Cell Expansion Market is poised to grow at sustainable CAGR for the next forecast year.
Market snapshot - 2025-2032
Global Market Size
USD 30.4 billion
Largest Segment
Consumables
Fastest Growth
Instruments
Growth Rate
10.3% CAGR
To get more reports on the above market click here to Buy The Report
Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented into biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Consumables led the product segment in 2023 and accounted for 46.7% of the market share. The segment is furthermore estimated to retain its dominant position throughout the forecast years. The availability of a wide range of commercial media and reagent products that are dedicated to specific types of cells contributes to the large revenue share of this segment. In addition, these products are convenient, ready to use, and are also available as serum-free formulations. For instance, in May 2023, Lonza introduced TheraPEAK T-VIVO Cell Culture Medium, a chemically defined medium optimized for the manufacturing of CAR T-cells. This non-animal-origin medium enhances consistency and process control and streamlines regulatory approval, accelerating cell therapy development.
As per cell expansion market outlook, the instruments segment is the fastest growing owing to the automation trend in bioreactors and other expansion platforms to enhance the efficiency of culturing procedures. This enables skilled labor time management to be efficient. In September 2022, Terumo Blood and Cell Technologies (Terumo BCT) launched the Quantum Flex Cell Expansion System, a bioreactor platform for cell and gene therapy (CGT) development and manufacturing. The platform aims to provide methods to automate the process, reduce time-consuming steps and optimize technology transfer. In this manner, the continuous commercialization and introduction of automated culturing equipment also is poised to drive revenue generation in the instruments segment.
The mammalian cell segment held the largest revenue share in 2023 and is expected to continue to dominate. This culture system is highly preferred in the manufacture of complex protein therapeutics due to its uptake pharmacology and functionality for post-translational studies in humans. Thus, most biopharmaceuticals, including monoclonal antibodies, specific interferons, thrombolytics, and various therapeutic enzymes, are produced using these culture systems. Fibroblasts and other differentiated cells have gained increasing importance in dermal wound healing and skin bioengineering, resulting in high numbers. Furthermore, 3D gingival fibroblast (GF) toroids are explored as an in vitro assay feasible and easy to perform biomaterial screening has expanded their rate.
Human stem cells have gained tremendous traction and are expected to witness the fastest CAGR during the forecast period. The increasing research activities in this field, the tremendous success of regenerative medicine is among the major factors from the rapid growth of this segment. Furthermore, the implementation of automated, robotic, and closed production systems in the production of clinical-grade mesenchymal stem cells drives the segment's expansion. For example, in June 2022, STEMCELL Technologies and PBS Biotech announced a joint venture to provide the PBS-MINI Bioreactor to researchers to increase human pluripotent stem cell (hPSC) cultures.
To get detailed analysis on other segments, Request For Free Sample Report
As per cell expansion market outlook, North America currently dominates the cell expansion market, mainly due to its advanced healthcare infrastructure, huge investments in R&D, and presence of leading biotechnology and pharmaceutical companies. North America dominates the global cell expansion market, largely due to its established biotechnology sector, significant R&D investments, and strong focus on regenerative medicine. The region is anticipated to retain its leading position in the coming years due to a rise in the funding initiatives by government agencies, which has accelerated the manufacturing of stem cells and the development of regenerative medicines and cellular therapy products. This, in turn, drives the demand for cell expansion platforms in this region.
Asia Pacific is expected to witness the fastest CAGR of over 15.0% during the forecast period, due to increasing initiatives by several local pharmaceutical and biotechnology companies to develop and commercialize their cellular therapies. Countries like China, Japan, and India are witnessing a surge in demand for stem cell therapies and biopharmaceutical production, driven by a growing prevalence of chronic diseases and an aging population. The region's cost-effective manufacturing capabilities and rapidly expanding clinical trial activities make it a global hub for cell-based research and production, contributing to its accelerated growth.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Applications in Biopharmaceutical Manufacturing
Growing Demand for Regenerative Medicine and Stem Cell Therapy
Legal and Ethical Challenges
High Cost of Cell Propagation Technology
Request Free Customization of this report to help us to meet your business objectives.
The cell expansion industry is characterized by fierce competition, with the rapid adoption of new technologies, cell-based therapies and increasing demand for the biopharmaceuticals by major market players focuses on strategic partnerships, acquisitions and innovation to maintain a competitive edge. This market also has an increasing number of start-ups and emerging companies introducing niche solutions, contributing to the dynamic environment.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to SkyQuest analysis, the cell expansion market is witnessing sturdy growth, driven by the growing demand for regenerative remedy, stem cell healing procedures, and biopharmaceutical manufacturing. The availability of well-characterized and highly productive cell lines contributes to the growth of the cell expansion market. However, demanding situations which include excessive expenses and regulatory hurdles persist, limiting massive adoption. Strategic investments inside revolutionary technology and the choice of ethical concerns may be critical for unlocking the capability of the market, paving the manner for breakthroughs in healthcare and biopharmaceutical manufacturing. The continuous advancements in genetic engineering technologies, such as CRISPR/Cas9, have facilitated the development of high-performing cell lines for protein expression.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 30.4 billion |
Market size value in 2032 | USD 73.46 billion |
Growth Rate | 10.3% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Cell Expansion Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell Expansion Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell Expansion Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell Expansion Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Cell Expansion Market size was valued at USD 27.6 Billion in 2023 and is poised to grow from USD 30.22 Billion in 2024 to USD 62.48 Billion by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).
The cell expansion industry is characterized by fierce competition, with the rapid adoption of new technologies, cell-based therapies and increasing demand for the biopharmaceuticals by major market players focuses on strategic partnerships, acquisitions and innovation to maintain a competitive edge. This market also has an increasing number of start-ups and emerging companies introducing niche solutions, contributing to the dynamic environment. 'Thermo Fisher Scientific Inc. (United States)', 'Merck KGaA (Germany)', 'Lonza Group Ltd. (Switzerland)', 'GE Healthcare (United States)', 'Sartorius AG (Germany)', 'Promega Corporation (United States)', 'Agilent Technologies, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Eppendorf AG (Germany)', 'Takara Bio Inc. (Japan)', 'GenScript Biotech Corporation (China)', 'CellGenix GmbH (Germany)', 'BD Biosciences (United States)', 'Novasep Holding S.A.S. (France)', 'OriGene Technologies, Inc. (United States)', 'Lonza Biologics Plc (United Kingdom)', 'Danaher Corporation (United States)', 'Wuxi AppTec Co., Ltd. (China)', 'Charles River Laboratories International, Inc. (United States)', 'Miltenyi Biotec GmbH (Germany)', 'New England Biolabs, Inc. (United States)', 'Qiagen N.V. (Netherlands)'
The widespread use of cellular expansion in biopharmaceutical development is another important growth driver. Biopharmaceuticals, such as the monoclonal antibodies, vaccines, and cell-based therapies, rely heavily on complex, scalable cell expansion pathways. The increasing prevalence of chronic diseases and the global demand for personalized medicines has created a need for high-quality biopharmaceuticals.
Application of 3D Cell Culture and Bioreactor Technology: A key component inside the cell expansion market trend is the shift from the traditional secondary cell culture systems to advanced 3D cell culture techniques. 3-dimensional cell cultures accurately mimic the biological environment of cells, enhancing cell function and viability. Technology is increasingly being used in regenerative medicine, cancer research and drug development.
As per cell expansion market outlook, North America currently dominates the cell expansion market, mainly due to its advanced healthcare infrastructure, huge investments in R&D, and presence of leading biotechnology and pharmaceutical companies. North America dominates the global cell expansion market, largely due to its established biotechnology sector, significant R&D investments, and strong focus on regenerative medicine. The region is anticipated to retain its leading position in the coming years due to a rise in the funding initiatives by government agencies, which has accelerated the manufacturing of stem cells and the development of regenerative medicines and cellular therapy products. This, in turn, drives the demand for cell expansion platforms in this region. Asia Pacific is expected to witness the fastest CAGR of over 15.0% during the forecast period, due to increasing initiatives by several local pharmaceutical and biotechnology companies to develop and commercialize their cellular therapies. Countries like China, Japan, and India are witnessing a surge in demand for stem cell therapies and biopharmaceutical production, driven by a growing prevalence of chronic diseases and an aging population. The region’s cost-effective manufacturing capabilities and rapidly expanding clinical trial activities make it a global hub for cell-based research and production, contributing to its accelerated growth.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35J2071
[email protected]
USA +1 351-333-4748